PERFORMANT HEALTHCARE INC (PFMT) Earnings History & Surprises

NASDAQ:PFMTUS71377E1055

Current stock price

3.56 USD
-0.12 (-3.26%)
At close:
3.56 USD
0 (0%)
After Hours:

PFMT Earnings overview

Past quarterly earnings results for PERFORMANT HEALTHCARE INC (PFMT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
N/A
Period
Q4 / 2024
EPS Estimate
-$0.02
Revenue Estimate
34.83M

Last Reported

Most Recent
Release Date
Nov 6, 2024
Period
Q3 / 2024
EPS Reported
-$0.03
EPS Surprise
1.96%
Revenue Surprise
-2.19%

Beat Rate

Last 8 Quarters
69%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2024 -0.03 -0.03 1.96% -200.00% 31.519M 32.224M -2.19% 5.20%
Q2 2024 -0.04 -0.05 21.57% 20.00% 29.362M 28.731M 2.20% 15.21%
Q1 2024 -0.05 -0.07 24.59% 16.67% 27.334M 26.357M 3.71% 6.24%
Q4 2023 0.02 0.01 292.16% - 32.567M 32.218M 1.08% 11.38%
Q3 2023 -0.01 -0.03 60.78% 50.00% 29.962M 28.43M 5.39% 10.24%
Q2 2023 -0.05 -0.05 -8.93% -25.00% 25.485M 27.207M -6.33% -0.76%
Q1 2023 -0.06 -0.06 1.96% -200.00% 25.729M 26.983M -4.65% -4.99%
Q4 2022 0.00 -0.02 100.00% 100.00% 29.24M 30.497M -4.12% -7.41%
Q3 2022 -0.02 -0.04 43.98% 33.33% 27.18M 27.121M 0.22% -4.90%
Q2 2022 -0.04 -0.06 28.70% -500.00% 25.68M 24.672M 4.09% -21.80%
Q1 2022 -0.02 -0.08 75.49% 60.00% 27.08M 23.532M 15.08% -13.73%
Q4 2021 -0.04 -0.02 -96.08% -150.00% 31.58M 30.409M 3.85% -21.13%
Q3 2021 -0.03 -0.08 63.24% -150.00% 28.58M 28.867M -0.99% -21.12%
Q2 2021 0.01 -0.05 121.79% 200.00% 32.84M 29.943M 9.68% -2.81%
Q1 2021 -0.05 -0.05 1.96% -225.00% 31.39M 31.861M -1.48% -31.60%
Q4 2020 0.08 0.03 161.44% - 40.04M 49.836M -19.66% -
Q3 2020 0.06 0.00 - - 36.23M 45.472M -20.32% -
Q2 2020 -0.01 -0.03 67.32% - 33.79M 42.942M -21.31% -
Q1 2020 0.04 -0.06 165.36% - 45.89M 39.576M 15.95% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

PFMT EPS Q2Q GrowthPFMT EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q2/24 Q4/24 Q2/25 Q4/25 0 -200 -400

Revenue Historical Q2Q growth and Acceleration

PFMT Revenue Q2Q GrowthPFMT Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 0 10 -10 -20 -30

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
4
Average EPS beat (4)
85.07%
Max EPS beat (4)
292.16%
Min EPS beat (4)
1.96%

Revenue beat statistics

Revenue beat (4)
3
Average Revenue beat (4)
1.20%
Max Revenue beat (4)
3.71%
Min Revenue beat (4)
-2.19%

Analysis

In the last 4 quarters, PFMT has consistently beaten EPS estimates in all releases
PFMT has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, PFMT has beaten the EPS estimates by 85.1% on average.
In the last 4 quarters, PFMT has beaten the revenue estimates by 1.2% on average.

PERFORMANT HEALTHCARE INC / PFMT Earnings FAQ

What is the most recent earnings date for PFMT stock?

PERFORMANT HEALTHCARE INC (PFMT) last reported earnings on 11/6/2024.

Can you provide information on whether PERFORMANT HEALTHCARE INC beat earnings estimates in the last quarter?

PERFORMANT HEALTHCARE INC (PFMT) beat EPS estimates and missed revenue estimates in the most recent quarter.

What percentage of the time does PFMT stock beat earnings estimates?

In the last 4 quarters, PERFORMANT HEALTHCARE INC (PFMT) has beaten EPS estimates in 4 out of 4 releases.